Literature DB >> 14165162

CORTICAL PH AND THE BLOOD-BRAIN BARRIER.

S I RAPOPORT.   

Abstract

Keywords:  ACETATES; ACETAZOLAMIDE; AMMONIUM COMPOUNDS; ANOXIA; ARACHNOID; BLOOD-BRAIN BARRIER; BRAIN ELECTROPHYSIOLOGY; CARBON DIOXIDE; CARBONATES; CATS; CEREBRAL CORTEX; EXPERIMENTAL LAB STUDY; HYDROCHLORIC ACID; HYDROGEN-ION CONCENTRATION; HYDROXIDES; LACTATES; PHARMACOLOGY; PHOSPHATES; RABBITS; SODIUM CHLORIDE

Mesh：

Substances：

Year:  1964        PMID： 14165162      PMCID： PMC1368811          DOI： 10.1113/jphysiol.1964.sp007327

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  24 in total

1.  Spreading cortical depression of Leao.

Authors:  W H MARSHALL
Journal:  Physiol Rev       Date:  1959-04       Impact factor: 37.312

2.  Localization of carbonic anhydrase in the nervous system.

Authors:  E GIACOBINI
Journal:  Science       Date:  1961-11-10       Impact factor: 47.728

3.  An explanation of the blood-brain barrier phenomenon.

Authors:  R EDSTROM
Journal:  Acta Psychiatr Neurol Scand       Date:  1958

4.  C14 studies in carbohydrate metabolism. IV. Characteristics of bicarbonate pool system in the rat.

Authors:  R A SHIPLEY; N BAKER; G E INCEFY; R E CLARK
Journal:  Am J Physiol       Date:  1959-07

5.  Effect of hyperoxia, hypercapnia, and hypoxia on blood-cerebrospinal fluid barrier.

Authors:  M LENDING; L B SLOBODY; J MESTERN
Journal:  Am J Physiol       Date:  1961-05

6.  Factors influencing the exchange of sodium between plasma and cerebrospinal fluid.

Authors:  R A FISHMAN
Journal:  J Clin Invest       Date:  1959-10       Impact factor: 14.808

7.  The importance of dissociaton constant and lipid-solubility in influencing the passage of drugs into the cerebrospinal fluid.

Authors:  B B BRODIE; H KURZ; L S SCHANKER
Journal:  J Pharmacol Exp Ther       Date:  1960-09       Impact factor: 4.030

8.  Mechanism of the anticonvulsant action of acetazoleamide, a carbonic anhydrase inhibitor.

Authors:  J G MILLICHAP; D M WOODBURY; L S GOODMAN
Journal:  J Pharmacol Exp Ther       Date:  1955-11       Impact factor: 4.030

9.  Passage of molecules through capillary wals.

Authors:  J R PAPPENHEIMER
Journal:  Physiol Rev       Date:  1953-07       Impact factor: 37.312

10.  Studies of formation, flow and absorption of cerebrospinal fluid. II. Studies with heavy water in the normal man.

Authors:  W H SWEET; B SELVERSTONE; S SOLOWAY; D STETTEN
Journal:  Surg Forum       Date:  1950
View more
  7 in total

1.  The use of microelectrodes for measurement of local H+ activity in the cortical subarachnoidal space of cats.

Authors:  W Schneider; M Wahl; W Kuschinsky; K Thurau
Journal:  Pflugers Arch       Date:  1977-11-25       Impact factor: 3.657

2.  Primary and secondary cerebrospinal fluid acidosis as a manifestation of cerebral lesions.

Authors:  A Prill; E Volles; W Dahlmann; F Grunwald
Journal:  Z Neurol       Date:  1974-03-29

3.  [The effect of oxytocin on the constant brain potential of anesthetized frogs].

Authors:  G Sterba; J Kormann
Journal:  Pflugers Arch Gesamte Physiol Menschen Tiere       Date:  1966

Review 4.  Fluid and ion transfer across the blood-brain and blood-cerebrospinal fluid barriers; a comparative account of mechanisms and roles.

Authors:  Stephen B Hladky; Margery A Barrand
Journal:  Fluids Barriers CNS       Date:  2016-10-31

5.  Chemosensitivity of cardiac muscle.

Authors:  E M Williams; J M Whyte
Journal:  J Physiol       Date:  1967-03       Impact factor: 5.182

6.  Acid-base changes in the brain in nonrespiratory acidosis and alkalosis.

Authors:  B K Siesjö; U Pontén
Journal:  Exp Brain Res       Date:  1966       Impact factor: 1.972

7.  Functional NHE1 expression is critical to blood brain barrier integrity and sumatriptan blood to brain uptake.

Authors:  Erika Liktor-Busa; Kiera T Blawn; Kathryn L Kellohen; Beth M Wiese; Vani Verkhovsky; Jared Wahl; Anjali Vivek; Seph M Palomino; Thomas P Davis; Todd W Vanderah; Tally M Largent-Milnes
Journal:  PLoS One       Date:  2020-05-29       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.